β-Sitosterol sensitizes MDA-MB-231 cells to TRAIL-induced apoptosis

Acta Pharmacologica Sinica

Volumn 29, Issue 3, 2008, Pages 341-348

  Park, Cheol ^a,b   Moon, Dong Oh ^c   Ryu, Chung Ho ^d   Choi, Byung Tae ^b   Lee, Won Ho ^b   Kim, Gi Young ^c   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

^c Jeju National University   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; TNF related apoptosis inducing ligand; sitosterol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; CASPASE INHIBITOR; LACTATE DEHYDROGENASE; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SITOSTEROL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN FUNCTION; WESTERN BLOTTING;

EID: 39849092986     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00761.x     Document Type: Article

References (32)

1. 1 Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, et al. Safety and antitumor activity or recombinant soluble Apo2 ligand. J Clin Invest 1999 ; 104: 155–62.
2. 2 Walczak H, Miller RE, Ariail K, Gliniak B, Griffth TS, Kubin M, et al. Tumoricidal activity of tumor necrosis factor‐related apoptosis‐inducing ligand in vivo. Nat Med 1999 ; 5: 157–63.
3. 3 Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain‐containing receptor for TRAIL. Science 1997 ; 277: 815–8.
4. 4 Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997 ; 276: 111–3.
5. 5 Srivastava RK. TRAIL/Apo‐2L: mechanisms and clinical applications in cancer. Neoplasia 2001 ; 3: 535–46.
6. 6 Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor‐related apoptosis‐inducing ligand/Apo‐2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 2003 ; 63: 5390–400.
7. 7 Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, et al. E1A sensitizes cancer cells to TRAIL‐induced apoptosis through enhancement of caspase activation. Mol Cancer Res 2005 ; 3: 219–26.
8. 8 Butler LM, Liapis V, Bouralexis S, Welldon K, Hay S, Thai LM, et al. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. Int J Cancer 2006 ; 119: 944–54.
9. 9 Awad AB, Fink CS. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 2000 ; 130: 2127–30.
10. 10 Vanhanen HT, Miettinen TA. Effects of unsaturated and saturated dietary plant sterols on their serum contents. Clin Chim Acta 1992 ; 205: 97–107.
11. 11 Muti P, Awad AB, Schunemann H, Fink CS, Hovey K, Freudenheim JL, et al. A plant food‐based diet modifes the serum β‐sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr 2003 ; 133 ; 4252–55.
12. 12 Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, Takahashi M. Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 1980 ; 40: 403–5.
13. 13 Gupta MB, Nath R, Srivastava N, Shanker K, Kishor K, Bhargava KP. Anti‐inflammatory and antipyretic activities of β‐sitosterol. Planta Med 1980 ; 39: 157–63.
14. 14 Garcia MD, Saenz MT, Gomez MA, Fernandez MA. Topical anti‐inflammatory activity of phytosterols isolated from Eryngium foetidum on chronic and acute inflammation models. Phytother Res 1999 ; 13: 78–80.
15. 15 Choi S, Kim KW, Choi JS, Han ST, Park YI, Lee SK, et al. Angiogenic activity of β‐sitosterol in the ischemia/reperfusion‐damaged brain of Mongolian gerbil. Planta Med 2002 ; 68: 330–5.
16. 16 Bouic PJ, Lamprecht JH. Plant sterols and sterolins: a review of their immune‐modulating properties. Altern Med Rev 1999 ; 4: 170–7.
17. 17 Bouic PJ. The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr Opin Clin Nutr Metab Care 2001 ; 4: 471–5.
18. 18 Clodi K, Wimmer D, Li Y, Goodwin R, Jaeger U, Mann G, et al. Expression of tumor necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) receptors and sensitivity to TRAIL‐induced apoptosis in primary B‐cell acute lymphoblastic leukemia cells. Br J Haematol 2000 ; 111: 580–6.
19. 19 Fulda S, Jeremias I, Debatin KM. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 2004 ; 23: 7611–20.
20. 20 MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, et al. Mechanisms of resistance to TRAIL‐induced apoptosis in primary B cell chronic lymphocytic leukemia. Oncogene 2002 ; 21: 6809–18.
21. 21 Awad AB, Roy R, Fink CS. β‐Sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA‐MB‐231 human breast cancer cells. Oncol Rep 2003 ; 10: 497–500.
22. 22 Awad AB, Williams H, Fink CS. Phytosterols reduce in vitro metastatic ability of MDA‐MB‐231 human breast caner cells. Nutr Cancer 2001 ; 40: 157–64.
23. 23 Awad AB, Downie A, Fink CS, Kim U. Dietary phytosterol inhibits the growth and metastasis of MDA‐MB‐231 human breast cancer cells grown in SCID mice. Anticancer Res 2000 ; 20: 821–4.
24. 24 Awad AB, Downie AC, Fink CS. Induction of growth and stimulation of apoptosis by β‐sitosterol treatment of MDA‐MB‐231 human breast cancer cells in culture. Int J Mol Med 2000 ; 5: 541–45.
25. 25 Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, et al. FADD/MORT1 and caspase‐8 are recruited to TRAIL receptors 1 and 2 are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000 ; 12: 599–609.
26. 26 Bratton SB, MacFarlane M, Cain K, Cohen GM. Protein complexes activate distinct caspase cascades in death receptor and stress‐induced apoptosis. Exp Cell Res 2000 ; 256: 27–33.
27. 27 Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997 ; 326: 1–16.
28. 28 Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta 1998 ; 1387: 17–31.
29. 29 Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999 ; 68: 383–424.
30. 30 Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF‐κB, survivin, Bc1‐2 and caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol 2004 ; 10: 22–5.
31. 31 LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, et al. Tumor‐cell resistance to death receptor‐induced apoptosis through mutational inactivation of the proapoptotic Bc1‐2 homolog Bax. Nat Med 2002 ; 8: 274–81.
32. 32 Kim EH, Kim SU, Shin DY, Choi KS. Roscovitine sensitizes glioma cells to TRAIL‐mediated apoptosis by downregulation of survivin and XIAP. Oncogene 2004 ; 23: 446–56.